Translational Development Acquisition Corp.

Translational Development Acquisition Corp. Share · KYG9008W1134 · TDACW (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Translational Development Acquisition Corp.
No Price
29.04.2026 19:05
Current Prices from Translational Development Acquisition Corp.
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
TDACW
USD
29.04.2026 19:05
0,10 USD
-
Share Float & Liquidity
Free Float 127,00 %
Shares Float 29,94 M
Shares Outstanding 23,58 M
Company Profile for Translational Development Acquisition Corp. Share
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Company Data

Name Translational Development Acquisition Corp.
Company Translational Development Acquisition Corp.
Symbol TDACW
Website https://www.translational-development.com
Primary Exchange XNAS NASDAQ
ISIN KYG9008W1134
Asset Class Share
Sector Financial Services
Industry Financial - Conglomerates
CEO Michael M. B. Hoffman
Country United States of America
Currency USD
Employees -
Address 52 E. 83rd Street, 10028 New York City
IPO Date 2018-06-13

Ticker Symbols

Name Symbol
NASDAQ TDACW
More Shares
Investors who hold Translational Development Acquisition Corp. also have the following shares in their portfolio:
INST.CRD.OF. 23/27 MTN
INST.CRD.OF. 23/27 MTN Bond
Roche Holdings Inc. DL-Notes 2024(24/29) Reg.S
Roche Holdings Inc. DL-Notes 2024(24/29) Reg.S Unknown